Indaptus Therapeutics Inc
NASDAQ:INDP
Indaptus Therapeutics Inc
NASDAQ:INDP
Price:
1.75
USD
9.37%
Market Closed
Market Cap:
$3.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Indaptus Therapeutics Inc
NASDAQ:INDP
|
US |
|
Merchants Bancorp
NASDAQ:MBIN
|
US |
|
2020 Bulkers Ltd
OSE:2020
|
BM |
|
D
|
Dundee Sustainable Technologies Inc
CNSX:DST
|
CA |
|
BKW AG
SIX:BKW
|
CH |
|
K
|
Karbon-X Corp
OTC:KARX
|
CA |
|
Chengdu Spaceon Electronics Co Ltd
SZSE:002935
|
CN |
|
Boardwalk Real Estate Investment Trust
TSX:BEI.UN
|
CA |
|
C
|
CSP International Fashion Group SpA
MIL:CSP
|
IT |
|
Z
|
Zhejiang Wanma Co Ltd
SZSE:002276
|
CN |
|
V
|
Volkswagen AG
DUS:VOW
|
DE |
|
Enerplus Corp
TSX:ERF
|
CA |
Balance Sheet
Balance Sheet Decomposition
Indaptus Therapeutics Inc
Indaptus Therapeutics Inc
Balance Sheet Decomposition is not available for
Indaptus Therapeutics Inc
Indaptus Therapeutics Inc
Balance Sheet
Indaptus Therapeutics Inc
Indaptus Therapeutics Inc
Currency: USD
| Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||
| Cash & Cash Equivalents |
2
|
5
|
3
|
1
|
3
|
6
|
24
|
16
|
53
|
39
|
9
|
15
|
39
|
10
|
13
|
6
|
9
|
|
| Cash Equivalents |
2
|
5
|
3
|
1
|
3
|
6
|
24
|
16
|
53
|
39
|
9
|
15
|
39
|
10
|
13
|
6
|
9
|
|
| Short-Term Investments |
0
|
5
|
2
|
3
|
5
|
2
|
7
|
2
|
2
|
1
|
1
|
0
|
0
|
17
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
1
|
1
|
1
|
1
|
0
|
0
|
2
|
0
|
2
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
1
|
1
|
1
|
1
|
0
|
0
|
2
|
0
|
2
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
2
|
0
|
1
|
1
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
|
| Total Current Assets |
2
|
11
|
6
|
5
|
9
|
8
|
33
|
21
|
56
|
44
|
14
|
15
|
40
|
27
|
14
|
7
|
9
|
|
| PP&E Net |
2
|
2
|
3
|
3
|
4
|
4
|
4
|
4
|
8
|
12
|
4
|
2
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
2
|
2
|
3
|
3
|
4
|
4
|
0
|
0
|
8
|
12
|
4
|
2
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
1
|
2
|
2
|
2
|
3
|
3
|
0
|
0
|
5
|
6
|
7
|
8
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
6
|
4
|
4
|
0
|
1
|
1
|
1
|
0
|
|
| Total Assets |
3
N/A
|
13
+282%
|
9
-28%
|
8
-15%
|
14
+76%
|
13
-9%
|
37
+197%
|
25
-33%
|
65
+161%
|
62
-5%
|
21
-65%
|
21
-2%
|
41
+94%
|
28
-31%
|
15
-47%
|
7
-51%
|
9
+27%
|
|
| Liabilities | ||||||||||||||||||
| Accounts Payable |
0
|
0
|
1
|
0
|
0
|
0
|
1
|
1
|
2
|
3
|
4
|
0
|
5
|
1
|
1
|
1
|
1
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
4
|
5
|
0
|
1
|
0
|
2
|
2
|
3
|
6
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
1
|
1
|
1
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
5
|
4
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
1
|
1
|
1
|
1
|
1
|
2
|
1
|
2
|
6
|
8
|
8
|
5
|
5
|
3
|
3
|
3
|
6
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
1
|
0
|
0
|
0
|
3
|
1
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
2
N/A
|
1
-40%
|
1
+24%
|
1
-29%
|
4
+377%
|
3
-31%
|
2
-46%
|
2
+23%
|
6
+185%
|
8
+39%
|
10
+22%
|
6
-35%
|
5
-26%
|
3
-27%
|
3
-17%
|
3
+19%
|
6
+81%
|
|
| Equity | ||||||||||||||||||
| Common Stock |
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
20
|
24
|
28
|
33
|
40
|
42
|
50
|
63
|
98
|
142
|
189
|
204
|
16
|
30
|
45
|
60
|
81
|
|
| Additional Paid In Capital |
22
|
35
|
35
|
39
|
49
|
51
|
85
|
85
|
156
|
195
|
200
|
217
|
51
|
54
|
57
|
64
|
84
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
2
N/A
|
12
+638%
|
8
-33%
|
7
-12%
|
9
+36%
|
9
+2%
|
36
+275%
|
23
-36%
|
59
+159%
|
54
-9%
|
12
-78%
|
15
+26%
|
36
+147%
|
25
-31%
|
12
-51%
|
4
-67%
|
3
-20%
|
|
| Total Liabilities & Equity |
3
N/A
|
13
+282%
|
9
-28%
|
8
-15%
|
14
+76%
|
13
-9%
|
37
+197%
|
25
-33%
|
65
+161%
|
62
-5%
|
21
-65%
|
21
-2%
|
41
+94%
|
28
-31%
|
15
-47%
|
7
-51%
|
9
+27%
|
|
| Shares Outstanding | ||||||||||||||||||
| Common Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
|
Switch to:
Switch to:
See Also
Discover More
